Miguel Cervero

Effect of Simultaneous Use of Highly Active Antiretroviral Therapy on Survival of HIV Patients With Tuberculosis

María Velasco, Virgilio Castilla, José Sanz et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 113 citations

Public Health, Infectious Diseases, Internal Medicine +16

Dual Therapy With Darunavir and Ritonavir Plus Lamivudine vs Triple Therapy With Darunavir and Ritonavir Plus Tenofovir Disoproxil Fumarate and Emtricitabine or Abacavir and Lamivudine for Maintenance of Human Immunodeficiency Virus Type 1 Viral Suppression: Randomized, Open-Label, Noninferiority DUAL-GESIDA 8014-RIS-EST45 Trial

Federico Pulido, Esteban Ribera, María Lagarde et al. · Clinical Infectious Diseases · 2017 · 102 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

Belén Gutiérrez‐Gutiérrez, Alberto M. Borobia, Antonio J. Carcas et al. · The Lancet Infectious Diseases · 2021 · 102 citations · Full text

Medicine, Clinical Sciences, Infectious Diseases +13

Effects of first-line antiretroviral therapy on the CD4/CD8 ratio and CD8 cell counts in CoRIS: a prospective multicentre cohort study

Sergio Serrano‐Villar, Javier Martínez‐Sanz, Raquel Ron et al. · The Lancet HIV · 2020 · 70 citations · Full text

Public Health, Immunology, Infectious Diseases +8

Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

Carolina Beltrán-Pavez, Miguel Gutiérrez-López, Marina Rubio-Garrido et al. · Scientific Reports · 2020 · 63 citations · Full text

Life Sciences, Infectious Diseases, Pediatrics +17